Feb 23 |
Baird starts Nuvalent at outperform, cites potential of lead assets
|
Feb 22 |
13 Best Short Squeeze Stocks To Buy Now
|
Feb 12 |
Nuvalent Initiates the Phase 2 Portion of ALKOVE-1 Clinical Trial for Patients with ALK-Positive NSCLC and other Solid Tumors
|
Feb 1 |
Nuvalent to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
|
Jan 8 |
Nuvalent announces 'OnTarget 2026' operating plan; aims for first approved product in 2026
|
Jan 8 |
Nuvalent Announces "OnTarget 2026" Operating Plan and Key Anticipated Milestones
|
Dec 25 |
Nuvalent: Strong Data, But Properly Valued
|
Dec 22 |
Director Anna Protopapas Sells 5,000 Shares of Nuvalent Inc (NUVL)
|
Nov 14 |
Nuvalent GAAP EPS of -$0.59 misses by $0.01
|
Nov 14 |
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter 2023 Financial Results
|